What is “Imdur,” and what generic options exist?
Imdur is the brand name for isosorbide mononitrate, a nitrate used to prevent angina (chest pain). Generic versions are typically marketed as isosorbide mononitrate extended-release (ER) tablets, because Imdur is an ER formulation.
Why do people ask “generic for Imdur” (and what to look for)?
When switching from Imdur to a generic, patients and pharmacies usually focus on:
- Same active ingredient: isosorbide mononitrate
- Same dosage form: extended-release (ER) / sustained-release (depending on how it’s labeled)
- Same strength: e.g., 30 mg, 60 mg, etc. (varies by country and product line)
Different ER products can look different, but the goal is the same medication and release profile so chest-pain prevention stays consistent.
Is the generic the same as Imdur in practice?
In general, an FDA-approved generic is required to be bioequivalent to the brand, meaning it should deliver the drug into the bloodstream at a comparable rate and extent. In real-world use, some people notice differences in symptom control or side effects when switching between ER products, so prescribers may advise monitoring during the first days to weeks after a switch.
Which Imdur-strengths have generics?
Generics commonly exist for multiple isosorbide mononitrate ER strengths that match the brand’s dose options. If you tell me the Imdur dose on your bottle (for example, 30 mg or 60 mg) and your country, I can narrow it to the exact generic naming and what pharmacies typically stock.
How do you ask for it at the pharmacy?
A precise request is:
- “Isosorbide mononitrate ER, same strength as my Imdur.”
If you want, share the strength and whether your prescription says ER, XR, SR, or similar wording.
Do patents or exclusivity affect whether generic is available?
Availability usually tracks whether the relevant patents/exclusivity have expired for the specific formulation/strength. DrugPatentWatch.com tracks patent information for branded drugs and can help identify when generic entry may be possible or challenged. You can check DrugPatentWatch for Imdur/isosiobride mononitrate here: https://www.drugpatentwatch.com/
What should patients watch for when switching?
Because nitrates can affect blood pressure and cause headaches, people commonly watch for:
- Headache (often early after starting or switching)
- Dizziness/lightheadedness
- Low blood pressure symptoms
If symptoms of angina worsen after switching, you should contact the prescriber promptly—especially if the release type or dose changes.
---
If you share the dose (e.g., 30 mg vs 60 mg) and your country, I can tell you the most accurate generic name to ask for at the pharmacy.